Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from CSPC Pharmaceutical Group ( (HK:1093) ) is now available.
CSPC Pharmaceutical Group Limited has announced a change in the composition of its Nomination Committee with the appointment of Ms. LI Quan as a member, effective June 27, 2025. This strategic move is expected to enhance the company’s governance structure and potentially influence its decision-making processes, reflecting its commitment to strengthening leadership and oversight.
The most recent analyst rating on (HK:1093) stock is a Buy with a HK$6.80 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products.
Average Trading Volume: 218,895,274
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$91.65B
Find detailed analytics on 1093 stock on TipRanks’ Stock Analysis page.